Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions

被引:4
|
作者
Spinillo, A
Debiaggi, M
Zara, F
Maserati, R
Polatti, F
De Santolo, A
机构
[1] Univ Pavia, Dept Obstet & Gynaecol, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Infect Dis & Microbiol, I-27100 Pavia, Italy
来源
关键词
D O I
10.1111/j.1471-0528.2001.00141.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To assess HIV-related nucleic acids in cervico-vaginal secretions and the factors associated with them. Design Observational study. Setting Department of Obstetrics and Gynaecology, University of Pavia, Italy. Population HIV-positive patients attending a cytology service. Methods Paired blood and cervico-vaginal lavage samples were obtained from 122 known HIV-seropositive patients during periodic visits for cytologic screening for lower genital tract neoplasia. Vaginal specimens for the diagnosis of bacterial vaginosis, trichomonas vaginalis and candida infection were also obtained. HIV-1-RNA in plasma, proviral HIV-1-DNA, cell associated and cell-free HIV-1-RNA in cervico-vaginal secretions were quantitatively evaluated by competitive polymerase chain reaction (c-PCR) and reverse transcriptase PCR (cRT-PCR). Main outcome measure Prevalences of HIV related nucleic acids in cervico-vaginal secretions and their univariate and multivariate associations with clinical variables. Results Proviral HIV-1 DNA, cell-associated and cell-free HIV-1 RNA were detected in 50% (61/122), 37.7% (46/122) and 32.8% (40/122) of the patients, respectively. In logistic regression analysis, the presence of HIV-1 RNA in blood was the factor which correlated best with the detection of HIV-1 DNA (OR = 5.48, 95% CI = 2.28-13.20), cell-associated (OR = 4.85; 95% CI = 1.89-12.45) and cell-free HIV-1 RNA (OR = 4.63, 95% CI = 1.74-12.33) in cervico-vaginal samples. However, between 20% and to 35% of patients who tested negative for blood HIV-1 RNA were positive for either HIV-1 DNA or HIV-1 RNA detection in cervico-vaginal lavages. Bacterial vaginosis was associated with an increased prevalence of cell-associated (OR = 3.58, 95% CI = 1.22-10.54) and cell-free HIV-1 RNA(OR = 2.94, 95% CI = 1.0-8.7) detection in cervico-vaginal secretions. Additional factors associated with increased prevalence of HIV-1 RNA detection were advanced stage of HIV disease and vulvovaginal candidiasis. Conclusions Although the presence of HIV-1 RNA in blood is the factor which correlates best with the detection of HIV-related nucleic acids in cervico-vaginal secretions, the shedding of HIV in the genital tract can occur in 20-30% of non-viremic subjects. Bacterial vaginosis and candida infection could have a facilitating role in local HIV viral replication and shedding.
引用
收藏
页码:634 / 641
页数:8
相关论文
共 50 条
  • [1] Identification of hepatitis C virus in cervico-vaginal secretions of infected women
    Tam, Kiran Tam
    Sison, Antonio
    Bagasra, Omar
    Tam, Hima Tam
    Jaspan, David
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) : S71 - S71
  • [2] Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women
    Spinillo, A
    Debiaggi, M
    Zara, F
    De Santolo, A
    Polatti, F
    Filice, G
    OBSTETRICS AND GYNECOLOGY, 2001, 97 (06): : 999 - 1004
  • [3] Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions
    Ellerbrock, TV
    Lennox, JL
    Clancy, KA
    Schinazi, RF
    Wright, TC
    Pratt-Palmore, M
    Evans-Strickfaden, T
    Schnell, C
    Pai, R
    Conley, LJ
    Parrish-Kohler, EE
    Bush, TJ
    Tatti, K
    Hart, CE
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (01): : 28 - 36
  • [4] Detection of human immunodeficiency virus type 1 and type 2 RNA and DNA in vaginal secretions.
    Critchlow, CW
    Hawes, SE
    Redman, MW
    Sow, PS
    Kiviat, NB
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (11) : s40 - s40
  • [5] Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication
    Hashemi, FB
    Mollenhauer, U
    Madsen, LD
    Sha, BE
    Nacken, W
    Moyer, MB
    Sorg, C
    Spear, GT
    AIDS, 2001, 15 (04) : 441 - 449
  • [6] The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions
    Villanueva, JM
    Ellerbrock, TV
    Lennox, JL
    Bush, TJ
    Wright, TC
    Pratt-Palmore, M
    Evans-Strickfaden, T
    Conley, LJ
    Schnell, C
    Hart, CE
    JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (02): : 170 - 177
  • [7] The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions
    Reichelderfer, PS
    Kovacs, A
    Wright, DJ
    Landay, A
    Cu-Uvin, S
    Burns, DN
    Cohn, J
    Coombs, RW
    JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (05): : 726 - 728
  • [8] Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1
    Zhang, SG
    Pointer, D
    Singer, G
    Feng, YF
    Park, K
    Zhao, LJ
    GENE, 1998, 212 (02) : 157 - 166
  • [9] The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions - Reply
    Lennox, JL
    Villanueva, JM
    Bush, TJ
    Ellerbrock, TV
    Hart, CE
    JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (05): : 728 - 729
  • [10] Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions
    Iversen, AKN
    Larsen, AR
    Jensen, T
    Fugger, L
    Balslev, U
    Wahl, S
    Gerstoft, J
    Mullins, JI
    Skinhoj, P
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05): : 1214 - 1220